Institutional investors purchased a net $6.2 million shares of TTNP during the quarter ended September 2014 and now own 9.93% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BROADFIN CAPITAL LLC Bought 6.4 Million shares of Titan Pharmaceuticals Inc